TY - JOUR
T1 - Glutamine synthetase induced spinal seizures in rats
AU - Shin, Dong Won
AU - Yoon, Young Sul
AU - Matsumoto, Masato
AU - Huang, Wencheng
AU - Ceraulo, Phil
AU - Young, Wise
PY - 2003/2
Y1 - 2003/2
N2 - Glutamine synthetase (GS) is a key enzyme in the regulation of glutamate neurotransmission in the central nervous system. It is responsible for converting glutamate to glutamine, consuming one ATP and NH3 in the process. Glutamate is neurotoxic when it accumulates in extracellular fluids. We investigated the effects of GS in both a spinal cord injury (SCI) model and normal rats. 0.1-ml of low (2- μM) and high (55- μM) concentrations of GS were applied, intrathecally, to the spinal cord of rats under pentobarbital anesthesia. Immediately after an intrathecal injection into the L1-L3 space, the rats developed convulsive movements. These movements initially consisted of myoclonic twitches of the paravertebral muscles close to the injection site, repeated tonic and clonic contractions and extensions of the hind limbs (hind limb seizures) that spread to the fore limbs, and finally rotational axial movements of the body. An EMG of the paravertebral muscles, fore and hind limbs, showed the extent of the muscle activities. GS (2- μM) caused spinal seizures in the rats after the SCI, and GS (6- μM) produced seizures in the uninjured anesthetized rats. Denatured GS (70 °C, 1 hour) also produced spinal seizures, although higher concentrations were required. We suggest that GS may be directly blocking the release of GABA, or the receptors, in the spinal cord.
AB - Glutamine synthetase (GS) is a key enzyme in the regulation of glutamate neurotransmission in the central nervous system. It is responsible for converting glutamate to glutamine, consuming one ATP and NH3 in the process. Glutamate is neurotoxic when it accumulates in extracellular fluids. We investigated the effects of GS in both a spinal cord injury (SCI) model and normal rats. 0.1-ml of low (2- μM) and high (55- μM) concentrations of GS were applied, intrathecally, to the spinal cord of rats under pentobarbital anesthesia. Immediately after an intrathecal injection into the L1-L3 space, the rats developed convulsive movements. These movements initially consisted of myoclonic twitches of the paravertebral muscles close to the injection site, repeated tonic and clonic contractions and extensions of the hind limbs (hind limb seizures) that spread to the fore limbs, and finally rotational axial movements of the body. An EMG of the paravertebral muscles, fore and hind limbs, showed the extent of the muscle activities. GS (2- μM) caused spinal seizures in the rats after the SCI, and GS (6- μM) produced seizures in the uninjured anesthetized rats. Denatured GS (70 °C, 1 hour) also produced spinal seizures, although higher concentrations were required. We suggest that GS may be directly blocking the release of GABA, or the receptors, in the spinal cord.
KW - EMG
KW - Glutamine synthetase
KW - Molecular effect
KW - Spinal seizure
UR - http://www.scopus.com/inward/record.url?scp=0037298095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037298095&partnerID=8YFLogxK
U2 - 10.3349/ymj.2003.44.1.125
DO - 10.3349/ymj.2003.44.1.125
M3 - Article
C2 - 12619185
AN - SCOPUS:0037298095
SN - 0513-5796
VL - 44
SP - 125
EP - 132
JO - Yonsei medical journal
JF - Yonsei medical journal
IS - 1
ER -